Aiml Resources (AIML) AI Stock Analysis

• Market Cap: C$11.63M
• Dividend Yield: N/A
• Average Volume (3M): 377.83K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.50
• Revenue Growth: -64.23%
• EPS Growth: 18.42%
• Country: CA
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): N/A
• Shares Outstanding: 211,415,850
• 10 Day Avg. Volume: 220,274
• 30 Day Avg. Volume: 377,826
• PEG Ratio: 0.07
• Price to Book (P/B): 4.95
• Price to Sales (P/S): 76.79
• P/FCF Ratio: -3.22
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 44 Neutral
• Price Target: C$0.00 ▼(-100.00% Downside)

The overall stock score of 44 reflects significant financial challenges, including operational inefficiencies and liquidity issues. While there is some positive short-term technical momentum, the overbought RSI and negative valuation metrics highlight potential risks. The absence of earnings call and corporate events data limits further insights.

Aiml Resources Business Overview & Revenue Model

Company Description

AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML). It focuses on offering a patent-pending personal health monitoring and management system for caregivers, patients, and healthcare professionals to access and utilize data for enhance recovery outcomes and healthy living, as well as digital health software and wearable technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. was incorporated in 2009 and is headquartered in Victoria, Canada.

How the Company Makes Money

AIML generates revenue through multiple key streams, including software licensing fees, subscription-based services, and consulting contracts. The company charges clients for access to its proprietary AI platforms, which are designed to improve data analysis and operational workflows. Additionally, AIML earns income by providing tailored consulting services to organizations looking to implement AI solutions, helping them to optimize their processes and achieve business goals. Strategic partnerships with technology providers and industry players also play a significant role in its revenue model, as these alliances enable AIML to expand its market reach and offer integrated solutions to customers.

Aiml Resources Financial Statement Overview

Summary

Aiml Resources is facing significant financial challenges, including negative net profit margins, declining revenue growth, and liquidity issues. The company shows operational inefficiencies and financial instability across its income statement, balance sheet, and cash flow statement.

Income Statement

Aiml Resources has faced significant challenges in its income statement, with negative net profit margins and declining revenue growth. The gross profit margin is high, but this is overshadowed by substantial EBIT and EBITDA losses, indicating operational inefficiencies. The company needs to address these issues to improve its financial health.

Balance Sheet

The balance sheet shows a relatively low debt-to-equity ratio, which is a positive sign of financial stability. However, the negative return on equity and fluctuating equity levels suggest underlying financial instability. Improving equity and asset management could enhance the company's financial position.

Cash Flow

The cash flow statement reveals consistent negative operating and free cash flows, indicating liquidity challenges. Despite a slight improvement in free cash flow growth, the company struggles to generate positive cash flow from operations, which is critical for sustainability.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	167.31K	167.31K	600.14K	487.50K	65.41K	0.00
Gross Profit	162.81K	162.81K	294.86K	466.01K	65.41K	0.00
EBITDA	-4.08M	-4.85M	-1.67M	-1.36M	-3.42M	-1.43M
Net Income	-4.65M	-4.59M	-3.29M	-1.42M	-3.17M	-2.73M
Balance Sheet
Total Assets	3.41M	3.41M	329.69K	1.51M	2.04M	3.59M
Cash, Cash Equivalents and Short-Term Investments	2.00M	2.00M	216.86K	14.56K	525.24K	3.49M
Total Debt	198.19K	198.19K	197.72K	859.98K	261.34K	320.29K
Total Liabilities	855.77K	855.77K	1.54M	1.79M	1.55M	1.51M
Stockholders Equity	2.60M	2.60M	-1.17M	-247.46K	1.08M	2.31M
Cash Flow
Free Cash Flow	-3.99M	-3.99M	-1.64M	-634.28K	-3.02M	-959.00K
Operating Cash Flow	-3.99M	-3.99M	-1.64M	-634.28K	-3.02M	-931.35K
Investing Cash Flow	-1.15K	-1.15K	-325.98K	-210.64K	-1.14M	-11.38K
Financing Cash Flow	5.78M	5.78M	2.16M	374.37K	1.27M	4.17M

Aiml Resources Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.06
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Negative
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AIML, the sentiment is Positive. The current price of 0.06 is above the 20-day moving average (MA) of 0.05, above the 50-day MA of 0.05, and below the 200-day MA of 0.07, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 73.12 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:AIML.

Aiml Resources Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
ADK	―	C$35.14M	-6.98	―	―	-47.10%	-19.32%
AIML	―	C$11.63M	-1.61	-1143.80%	―	-64.23%	18.42%
CHS	―	C$11.49M	―	―	―	12.44%	74.38%
UDOC	―	$14.89M	-2.48	―	―	―	21.61%
AIDR	―	C$71.54M	―	-202.19%	―	―	40.17%

Aiml Resources Corporate Events

AIML Innovations Launches AI-Powered ECG Pilot with Canadian Cardiology Clinic

AI/ML Innovations Inc. announced that its subsidiary, NeuralCloud Solutions, is launching a pilot program with a Canadian cardiology clinic to implement its AI-powered ECG analysis platform, CardioYield™. This initiative aims to enhance the accuracy and efficiency of Holter ECG analysis through advanced AI signal processing, potentially improving clinical workflows and diagnostic precision. The pilot will start with internal validation, followed by in-clinic testing, and aims for full integration pending regulatory clearance. This collaboration represents a significant step in AIML’s mission to deliver AI-driven healthcare solutions and could set a benchmark for AI-driven reporting improvements in cardiology.

AIML Innovations Launches Cardiac Care Pilot in Jamaica

AI/ML Innovations Inc.’s subsidiary, NeuralCloud Solutions, in collaboration with Heartdent Center Ltd., has launched a pilot project in Jamaica to advance cardiac care using their AI-powered platform, CardioYield™. This initiative aims to provide affordable, accurate, and scalable Holter diagnostics, addressing the urgent need for accessible cardiac diagnostics in Jamaica, where cardiovascular disease is a leading cause of death. The pilot project will evaluate the integration and operational impact of CardioYield™ in Heartdent Center’s practice, potentially setting new standards for patient-centered care and improving patient outcomes through timely and accurate diagnosis.

AIML Innovations Launches AI-Powered ECG Reporting Pilot with Toronto Heart Centre

AI/ML Innovations Inc.’s subsidiary, NeuralCloud Solutions, has launched a pilot program with the Toronto Heart Centre to test CardioYield™, an AI-powered Holter ECG reporting tool. The study aims to evaluate the efficiency and quality improvements in ECG analysis and reporting compared to current industry standards. This collaboration is expected to enhance clinical workflows, benefiting both clinicians and patients by potentially improving speed and diagnostic reliability.

AI/ML Innovations and BC Brain Wellness Program Launch Heart-Brain Connection Pilot

AI/ML Innovations Inc. has announced a pilot project in collaboration with the BC Brain Wellness Program to explore the heart-brain connection using its MaxYield ECG technology. This initiative aims to analyze cardiac responses in individuals with neurological conditions during exercise, potentially uncovering insights into the relationship between heart activity and brain health. The project marks an important step in expanding AIML’s technology into neurology, with implications for future clinical research and improved care through interdisciplinary AI applications.

AI/ML Innovations Inc. Closes Oversubscribed Private Placement and Extends Warrant Expiry

AI/ML Innovations Inc. announced the successful closing of an oversubscribed private placement, raising $2,128,595, exceeding its initial target of $1,550,000. The funds will be used for general working capital, and the placement involved significant insider participation, constituting a related party transaction under regulatory guidelines. Additionally, the company extended the expiry date of existing share purchase warrants from a previous financing round, reflecting its strategic financial management.

AI/ML Innovations Inc. Announces $1.55 Million Private Placement

AI/ML Innovations Inc. announced a non-brokered private placement offering of up to 31,000,000 units at $0.05 per unit, aiming to raise $1,550,000. The proceeds will be used for working capital, and the offering includes common shares and warrants, subject to a hold period. The placement is contingent on necessary approvals, and finder’s fees may be paid to those assisting in the sale.

AIML Innovations Inc. Enhances Transparency with Amended Disclosure Filing

AIML Innovations Inc. has filed an amended and restated management’s discussion and analysis to address disclosure deficiencies identified by the British Columbia Securities Commission. The amendments include enhanced disclosure on new strategic initiatives, R&D activities, operational results, acquisitions, and payments to related parties. Additionally, the filing discusses an exit agreement with Tech2Heal and other minor changes. This move aims to improve transparency and provide stakeholders with a clearer understanding of the company’s recent activities and strategic direction.

AIML Innovations Completes Restructuring of Quantum Sciences Acquisition

AIML Innovations Inc. has successfully completed the restructuring of its acquisition of Quantum Sciences Ltd., initially finalized in December 2024. The restructuring, announced in April 2025, was executed as planned, except for the non-completion of a reseller agreement with Mark Orsmond and the retention of intellectual property rights for the ‘meApp’ application by AIML. This strategic move is expected to enhance AIML’s operational capabilities and strengthen its position in the digital health sector.